{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:13:26Z","timestamp":1793294006916,"version":"4.5.0"},"reference-count":286,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T00:00:00Z","timestamp":1687651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.imbio.2023.152410","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T19:14:40Z","timestamp":1685992480000},"page":"152410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4632-9640","authenticated-orcid":false,"given":"T.M.","family":"Hallam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Andreadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2023.152410_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4049\/jimmunol.107.1.19","article-title":"Deficiency of C3 inactivator in man","volume":"107","author":"Abramson","year":"1971","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1651-2227.1981.tb05772.x","article-title":"Synthesis of two components of human complement, beta 1H and C3bINA, during fetal life","volume":"70","author":"Adinolfi","year":"1981","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.imbio.2023.152410_b0015","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/1744-9987.13634","article-title":"Clinical characterization and identification of rare genetic variants in atypical hemolytic uremic syndrome: A Swedish retrospective observational study","volume":"25","author":"Akesson","year":"2021","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.imbio.2023.152410_b0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1172-7-42","article-title":"Complement factor I deficiency: a not so rare immune defect: characterization of new mutations and the first large gene deletion","volume":"7","author":"Alba-Dominguez","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.imbio.2023.152410_b0025","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1111\/ajt.12297","article-title":"Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations","volume":"13","author":"Alberti","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.imbio.2023.152410_b0030","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1106746108","article-title":"Unique structure of iC3b resolved at a resolution of 24 \u00c5 by 3D-electron microscopy","volume":"108","author":"Alcorlo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imbio.2023.152410_b0035","first-page":"1253","article-title":"Complement factor I and age-related macular degeneration","volume":"20","author":"Alexander","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.imbio.2023.152410_b0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM197002122820701","article-title":"Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3)","volume":"282","author":"Alper","year":"1970","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2023.152410_b0045","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1172\/JCI106417","article-title":"Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection","volume":"49","author":"Alper","year":"1970","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2023.152410_b0050","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1073\/pnas.69.10.2910","article-title":"Inactivator of the third component of complement as an inhibitor in the properdin pathway","volume":"69","author":"Alper","year":"1972","journal-title":"PNAS"},{"key":"10.1016\/j.imbio.2023.152410_b0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/bj2240389","article-title":"Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38 kDa tryptic fragment of factor H","volume":"224","author":"Alsenz","year":"1984","journal-title":"Biochem. J"},{"key":"10.1016\/j.imbio.2023.152410_b0060","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1042\/bj2320841","article-title":"Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H","volume":"232","author":"Alsenz","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.imbio.2023.152410_b0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1423-0410.1989.tb00835.x","article-title":"Pasteurisation of a factor I (C3b inactivator) concentrate from human plasma","volume":"57","author":"Alsoe","year":"1989","journal-title":"Vox Sang."},{"key":"10.1016\/j.imbio.2023.152410_b0070","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41433-019-0501-4","article-title":"Early local activation of complement in aqueous humour of patients with age-related macular degeneration","volume":"33","author":"Altay","year":"2019","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.imbio.2023.152410_b0075","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000689","article-title":"Complement factor I deficiency: A potentially treatable cause of fulminant cerebral inflammation","volume":"7","author":"Altmann","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.imbio.2023.152410_b0080","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1365-3083.2001.00931.x","article-title":"Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H","volume":"53","author":"Amadei","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/hum.1990.1.4-371","article-title":"September 14, 1990: the beginning","volume":"1","author":"Anderson","year":"1990","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.imbio.2023.152410_b0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The Pivotal Role of the Complement System in Aging and Age-related Macular Degeneration: Hypothesis Re-visited","volume":"29","author":"Anderson","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.imbio.2023.152410_b0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/j.ajkd.2015.04.010","article-title":"Discontinuation of eculizumab treatment in atypical hemolytic uremic syndrome: an update","volume":"66","author":"Ardissino","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.imbio.2023.152410_b0100","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ekir.2021.03.885","article-title":"Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality","volume":"6","author":"Ardissino","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.imbio.2023.152410_b0105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2249.2003.02077.x","article-title":"Molecular characterization of homozygous hereditary factor I deficiency","volume":"131","author":"Baracho","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0110","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.kint.2015.11.024","article-title":"Complement receptor 3 mediates renal protection in experimental C3 glomerulopathy","volume":"89","author":"Barbour","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2023.152410_b0115","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ekir.2021.03.884","article-title":"Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults","volume":"6","author":"Barbour","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.imbio.2023.152410_b0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3476(84)80593-4","article-title":"Restoration of complement function in vivo by plasma infusion in factor I (C3b inactivator) deficiency","volume":"104","author":"Barrett","year":"1984","journal-title":"J. Pediatr."},{"key":"10.1016\/j.imbio.2023.152410_b0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.clim.2015.05.004","article-title":"Novel CFI mutation in a patient with leukocytoclastic vasculitis may redefine the clinical spectrum of Complement Factor I deficiency","volume":"160","author":"Bay","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0130","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.molimm.2010.03.007","article-title":"Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d","volume":"47","author":"Bhattacharjee","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ki.2009.472","article-title":"Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome","volume":"77","author":"Bienaime","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2023.152410_b0140","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/archinte.1993.00410110078012","article-title":"Complement factor I deficiency with recurrent aseptic meningitis","volume":"153","author":"Bonnin","year":"1993","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.imbio.2023.152410_b0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ekir.2022.10.013","article-title":"Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study","volume":"8","author":"Bouwmeester","year":"2023","journal-title":"Kidney International Reports"},{"key":"10.1016\/j.imbio.2023.152410_b0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2215\/CJN.00050505","article-title":"Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background","volume":"1","author":"Bresin","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_b0155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.imbio.2023.152410_b0160","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic Microangiopathy and the Kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_bib1426","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022018833","article-title":"Atypical haemolytic uraemic syndrome in the era of terminal complement inhibition- An observational cohort study.","author":"Brocklebank","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2023.152410_b0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s10875-012-9767-z","article-title":"Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis","volume":"33","author":"Broderick","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0170","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2215\/CJN.00280117","article-title":"Hemolytic Uremic Syndrome in Pregnancy and Postpartum","volume":"12","author":"Bruel","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_b0175","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1681\/ASN.2018070759","article-title":"Genetic analysis of 400 patients refines understanding and implicates a new gene in atypical hemolytic uremic syndrome","volume":"29","author":"Bu","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.imbio.2023.152410_b0180","article-title":"A candidate prognostic biomarker complement factor I promotes malignant progression in glioma","volume":"8","author":"Cai","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.imbio.2023.152410_b0185","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2023.152410_b0190","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1042\/bj2420849","article-title":"Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones","volume":"242","author":"Catterall","year":"1987","journal-title":"Biochem. J"},{"key":"10.1016\/j.imbio.2023.152410_b0195","doi-asserted-by":"crossref","first-page":"13918","DOI":"10.1021\/bi9805184","article-title":"Possible arrangement of the five domains in human complement factor I as determined by a combination of X-ray and neutron scattering and homology modeling","volume":"37","author":"Chamberlain","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.imbio.2023.152410_b0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI71866","article-title":"Complement factor H-related hybrid protein deregulates complement in dense deposit disease","volume":"124","author":"Chen","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2023.152410_b0205","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3389\/fimmu.2017.01778","article-title":"Bruch's membrane compartmentalizes complement regulation in the eye with implications for therapeutic design in age-related macular degeneration","volume":"8","author":"Clark","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0210","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1073\/pnas.82.3.859","article-title":"Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines","volume":"82","author":"Cole","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imbio.2023.152410_b0215","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1600-6143.2009.02647.x","article-title":"Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP","volume":"9","author":"Cruzado","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.imbio.2023.152410_b0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ejh.13430","article-title":"The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management","volume":"105","author":"Darbari","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.imbio.2023.152410_b0225","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.4049\/jimmunol.132.4.1960","article-title":"Physiologic inactivation of fluid phase c3b: isolation and structural analysis of Cc, C C3dg and C3g","volume":"132","author":"Davis","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0230","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/hmg\/ddaa114","article-title":"Effect of rare coding variants in the CFI gene on Factor I expression levels","volume":"29","author":"de Jong","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0235","article-title":"Functional analysis of variants in complement factor i identified in age-related macular degeneration and atypical hemolytic uremic syndrome","volume":"12","author":"de Jong","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0240","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-3083.2003.01326.x","article-title":"Ontogeny of Complement Regulatory Proteins \u2013 Concentrations of Factor H, Factor I, C4b-Binding Protein, Properdin and Vitronectin in Healthy Children of Different Ages and in Adults","volume":"58","author":"De Paula","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0245","first-page":"1","article-title":"Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration","volume":"62","author":"Demirs","year":"2021","journal-title":"Physiology and Pharmacology"},{"key":"10.1016\/j.imbio.2023.152410_b0250","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41433-021-01765-x","article-title":"Complement cascade inhibition in geographic atrophy: a review","volume":"36","author":"Desai","year":"2022","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.imbio.2023.152410_b0255","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.4049\/jimmunol.149.8.2592","article-title":"Ultrastructures and interactions of complement factors H and I","volume":"149","author":"DiScipio","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.958121","article-title":"Proprotein Convertases and the Complement System","volume":"13","author":"Dobo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0265","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.anai.2020.07.008","article-title":"Complement factor I deficiency in a 3-year-old boy with glomerulonephritis","volume":"125","author":"Donegan","year":"2020","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-021-00239-9","article-title":"Functional expression of complement factor I following AAV- mediated gene delivery in the retina of mice and human cells","author":"Dreismann","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.imbio.2023.152410_b0275","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13149","article-title":"Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway","volume":"313","author":"Dreismann","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2023.152410_b0280","doi-asserted-by":"crossref","first-page":"e054536","DOI":"10.1136\/bmjopen-2021-054536","article-title":"Safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm study","volume":"12","author":"Dunn","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.imbio.2023.152410_b0285","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.imbio.2023.152410_b0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/imr.13148","article-title":"Therapeutic regulation of complement activation in extracorporeal circuits and intravascular treatments with special reference to the alternative pathway amplification loop","volume":"313","author":"Ekdahl","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2023.152410_b0295","first-page":"2295","article-title":"GT005, a gene therapy for the treatment of dry age-related macular degeneration (AMD)","volume":"61","author":"Ellis","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.imbio.2023.152410_b0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imr.12474","article-title":"Evolution of the complement system: from defense of the single cell to guardian of the intravascular space","volume":"274","author":"Elvington","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2023.152410_b0305","first-page":"394","article-title":"Variable expression of homozygous C3b inactivator deficiency","volume":"26","author":"Eng","year":"1978","journal-title":"Clin. Res."},{"key":"10.1016\/j.imbio.2023.152410_b0310","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.molimm.2005.11.008","article-title":"Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree","volume":"43","author":"Esparza-Gordillo","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0315","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ejhg.2008.140","article-title":"Variation near complement factor I is associated with risk of advanced AMD","volume":"17","author":"Fagerness","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0320","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1182\/blood-2008-03-144691","article-title":"Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"112","author":"Fakhouri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2023.152410_b0325","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.imbio.2023.152410_b0330","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020005221","article-title":"Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group","volume":"136","author":"Fakhouri","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2023.152410_b0335","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood.2020009280","article-title":"Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study","volume":"137","author":"Fakhouri","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2023.152410_b0340","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.4049\/jimmunol.119.4.1248","article-title":"Purification of C3b inactivator and demonstration of its two polypeptide chain structure","volume":"119","author":"Fearon","year":"1977","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0345","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00006454-199108000-00011","article-title":"Increased susceptibility to infection in children with congenital deficiency of factor I","volume":"10","author":"Floret","year":"1991","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.imbio.2023.152410_b0350","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.15252\/embj.201593673","article-title":"Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode","volume":"35","author":"Forneris","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.imbio.2023.152410_b0355","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10875-017-0447-x","article-title":"Early Versus Late Diagnosis of Complement Factor I Deficiency: Clinical Consequences Illustrated in Two Families with Novel Homozygous CFI Mutations","volume":"37","author":"Franco-Jarava","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0360","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0365","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_b0370","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of Age-Related Macular Degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.imbio.2023.152410_b0375","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0380","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/diagnostics11030434","article-title":"Synovial Complement Factors in Patients with Periprosthetic Joint Infection after Undergoing Revision Arthroplasty of the Hip or Knee Joint","volume":"11","author":"Fr\u00f6schen","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.imbio.2023.152410_b0385","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(10)60670-8","article-title":"Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis","volume":"376","author":"Gale","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2023.152410_b0390","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00467-006-0320-2","article-title":"A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome","volume":"22","author":"Geelen","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_b0395","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamaophthalmol.2016.4604","article-title":"The Functional Effect of Rare Variants in Complement Genes on C3b Degradation in Patients With Age-Related Macular Degeneration","volume":"135","author":"Geerlings","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.imbio.2023.152410_b0400","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/00365540510034536","article-title":"Complement factor I deficiency associated with recurrent infections, vasculitis and immune complex glomerulonephritis","volume":"37","author":"Genel","year":"2005","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.imbio.2023.152410_b0405","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.901876","article-title":"Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation","volume":"13","author":"Gerogianni","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0410","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1084\/jem.141.5.1221","article-title":"The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b)","volume":"141","author":"Gitlin","year":"1975","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2023.152410_b0415","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.imbio.2016.05.002","article-title":"Chromosomal rearrangement-A rare cause of complement factor I associated atypical haemolytic uraemic syndrome","volume":"221","author":"Gleeson","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2023.152410_b0420","series-title":"Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome","author":"Glover","year":"2022"},{"key":"10.1016\/j.imbio.2023.152410_b0425","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng1750","article-title":"Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration","volume":"38","author":"Gold","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0430","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1016\/S0021-9258(20)82168-1","article-title":"Biosynthesis and postsynthetic processing of human C3b\/C4b inactivator (factor I) in three hepatoma cell lines","volume":"259","author":"Goldberger","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2023.152410_b0435","doi-asserted-by":"crossref","first-page":"10065","DOI":"10.1016\/S0021-9258(18)61076-2","article-title":"Human complement factor I: Analysis of cDNA-derived primary structure and assignment of its gene to chromosome 4","volume":"262","author":"Goldberger","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2023.152410_b0440","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1001\/archneur.58.11.1923","article-title":"Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation","volume":"58","author":"Gonz\u00e1lez-Rubio","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.imbio.2023.152410_b0445","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2012.05.009","article-title":"Factor H autoantibodies in membranoproliferative glomerulonephritis","volume":"52","author":"Goodship","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0450","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2023.152410_b0455","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.dci.2016.03.009","article-title":"The complement system of elasmobranches revealed by liver transcriptome analysis of a hammerhead shark","volume":"61","author":"Goshima","year":"2016","journal-title":"Sphyrna zygaena. Dev Comp Immunol"},{"key":"10.1016\/j.imbio.2023.152410_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152000","article-title":"Anti-complement factor I antibody associated atypical hemolytic uremic syndrome - A new insight for future perspective!","volume":"225","author":"Govindarajan","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2023.152410_b0465","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nri2231","article-title":"Complement driven by conformational changes","volume":"8","author":"Gros","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0470","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.2005.02988.x","article-title":"Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family","volume":"143","author":"Grumach","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0475","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10875-013-9944-8","article-title":"Complete factor I deficiency due to dysfunctional factor I with recurrent aseptic meningo-encephalitis","volume":"33","author":"Haerynck","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0480","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.imbio.2023.152410_b0485","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.imbio.2023.152410_b0490","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/stem.2708","article-title":"An Induced Pluripotent Stem Cell Patient Specific Model of Complement Factor H (Y402H) Polymorphism Displays Characteristic Features of Age-Related Macular Degeneration and Indicates a Beneficial Role for UV Light Exposure","volume":"35","author":"Hallam","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.imbio.2023.152410_b0495","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.61.6.18","article-title":"Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration","volume":"61","author":"Hallam","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.imbio.2023.152410_b0500","doi-asserted-by":"crossref","first-page":"1028760","DOI":"10.3389\/fimmu.2022.1028760","article-title":"A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative CFI variants in age-related macular degeneration","volume":"13","author":"Hallam","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0505","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0510","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molimm.2018.06.008","article-title":"Developments in anti-complement therapy; from disease to clinical trial","volume":"102","author":"Harris","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0515","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0161-5890(80)90119-4","article-title":"The physiological breakdown of the third component of human complement","volume":"17","author":"Harrison","year":"1980","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0520","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0161-5890(80)90074-7","article-title":"Novel cleavage products of the third component of human complement","volume":"17","author":"Harrison","year":"1980","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0525","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2023.152410_b0530","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmology"},{"key":"10.1016\/j.imbio.2023.152410_b0535","series-title":"The Regulators of Complement Activation (RCA) Gene Cluster","first-page":"381 pp.","author":"Hourcade","year":"1989"},{"key":"10.1016\/j.imbio.2023.152410_b0540","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molimm.2016.01.010","article-title":"Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome","volume":"71","author":"Iatropoulos","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0545","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ekir.2019.04.003","article-title":"A Multimodality Approach to Assessing Factor I Genetic Variants in Atypical Hemolytic Uremic Syndrome","volume":"4","author":"Java","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.imbio.2023.152410_b0550","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/tvst.9.9.37","article-title":"Functional Analysis of Rare Genetic Variants in Complement Factor I (CFI) using a Serum-Based Assay in Advanced Age-related Macular Degeneration","volume":"9","author":"Java","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.imbio.2023.152410_b0555","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1093\/hmg\/ddac103","article-title":"Functional analysis of rare genetic variants in complement factor I in advanced age-related macular degeneration","volume":"31","author":"Java","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100146","article-title":"Evaluating a Causal Relationship between Complement Factor I Protein Level and Advanced Age-Related Macular Degeneration Using Mendelian Randomization","volume":"2","author":"Jones","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.imbio.2023.152410_b0565","doi-asserted-by":"crossref","first-page":"e0272260","DOI":"10.1371\/journal.pone.0272260","article-title":"An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access","volume":"17","author":"Jones","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.imbio.2023.152410_b0570","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/eji.1830220131","article-title":"In vitro biosynthesis of complement factor I by human endothelial cells","volume":"22","author":"Julen","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0575","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2023.152410_b0580","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1073\/pnas.1017087108","article-title":"Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement","volume":"108","author":"Kajander","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.imbio.2023.152410_b0585","unstructured":"Kavanagh, D., Marchbank, K., 2020. Recombinant mature complement factor i."},{"key":"10.1016\/j.imbio.2023.152410_b0590","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ki.2011.330","article-title":"Interpretation of genetic variants of uncertain significance in atypical hemolytic uremic syndrome","volume":"81","author":"Kavanagh","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2023.152410_b0595","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2005010103","article-title":"Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome","volume":"16","author":"Kavanagh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.imbio.2023.152410_b0600","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molimm.2007.05.004","article-title":"Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome","volume":"45","author":"Kavanagh","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0605","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1055\/s-0030-1262887","article-title":"Transplantation in atypical hemolytic uremic syndrome","volume":"36","author":"Kavanagh","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.imbio.2023.152410_b0610","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2215\/CJN.05750611","article-title":"Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?","volume":"7","author":"Kavanagh","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_b0615","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_b0620","first-page":"3861","article-title":"Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels","volume":"24","author":"Kavanagh","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0625","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1084\/jem.150.5.1202","article-title":"Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b","volume":"150","author":"Kazatchkine","year":"1979","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2023.152410_b0630","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/humu.24242","article-title":"Prevalence and phenotype associations of complement factor I mutations in geographic atrophy","volume":"42","author":"Khan","year":"2021","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.imbio.2023.152410_b0635","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.imbio.2009.01.003","article-title":"Multi-component complement system of Cnidaria: C3, Bf, and MASP genes expressed in the endodermal tissues of a sea anemone","volume":"214","author":"Kimura","year":"2009","journal-title":"Nematostella vectensis. Immunobiology"},{"key":"10.1016\/j.imbio.2023.152410_b0640","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.imbio.2023.152410_b0645","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/eji.1830261017","article-title":"Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H","volume":"26","author":"K\u00fchn","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0650","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0161-5890(93)90040-I","article-title":"Characterization of xenopus laevis complement factor I structure\u2014conservation of modular structure except for an unusual insert not present in human factor I","volume":"30","author":"Kunnath-Muglia","year":"1993","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0655","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.imbio.2019.05.003","article-title":"The story of complement factor I","volume":"224","author":"Lachmann","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2023.152410_b0660","doi-asserted-by":"crossref","unstructured":"Lachmann, P.J., Muller-Eberhard, H.J. 1968. The demonstration in human serum of \u201cconglutinogen-activating factor\u201d and its effect on the third component of complement. Journal of immunology (Baltimore, Md.: 1950) 100, 691.","DOI":"10.4049\/jimmunol.100.4.691"},{"key":"10.1016\/j.imbio.2023.152410_b0665","first-page":"109","article-title":"The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation","volume":"21","author":"Lachmann","year":"1975","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0670","doi-asserted-by":"crossref","unstructured":"Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., DeStafano, A.L., Bis, J.C., Beecham, G.W., Grenier-Boley, B., Russo, G., Thorton-Wells, T.A., Jones, N., Smith, A.V., Chouraki, V., Thomas, C., Ikram, M.A., Zelenika, D., Vardarajan, B.N., Kamatani, Y., Lin, C.F., Gerrish, A., Schmidt, H., Kunkle, B., Dunstan, M.L., Ruiz, A., Bihoreau, M.T., Choi, S.H., Reitz, C., Pasquier, F., Cruchaga, C., Craig, D., Amin, N., Berr, C., Lopez, O.L., De Jager, P.L., Deramecourt, V., Johnston, J.A., Evans, D., Lovestone, S., Letenneur, L., Moron, F.J., Rubinsztein, D.C., Eiriksdottir, G., Sleegers, K., Goate, A.M., Fievet, N., Huentelman, M.W., Gill, M., Brown, K., Kamboh, M.I., Keller, L., Barberger-Gateau, P., McGuiness, B., Larson, E.B., Green, R., Myers, A.J., Dufouil, C., Todd, S., Wallon, D., Love, S., Rogaeva, E., Gallacher, J., St George-Hyslop, P., Clarimon, J., Lleo, A., Bayer, A., Tsuang, D.W., Yu, L., Tsolaki, M., Bossu, P., Spalletta, G., Proitsi, P., Collinge, J., Sorbi, S., Sanchez-Garcia, F., Fox, N.C., Hardy, J., Deniz Naranjo, M.C., Bosco, P., Clarke, R., Brayne, C., Galimberti, D., Mancuso, M., Matthews, F., European Alzheimer's Disease, I., Genetic, Environmental Risk in Alzheimer's, D., Alzheimer's Disease Genetic, C., Cohorts for, H., Aging Research in Genomic, E., Moebus, S., Mecocci, P., Del Zompo, M., Maier, W., Hampel, H., Pilotto, A., Bullido, M., Panza, F., Caffarra, P., et al. 2013. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 45, 1452.","DOI":"10.1038\/ng.2802"},{"key":"10.1016\/j.imbio.2023.152410_b0675","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0680","doi-asserted-by":"crossref","unstructured":"Lashkari, K., Teague, G., Chen, H., Lin, Y.-q., Kumar, S., Mclaughlin, M.M., Lo, F.J. 2018. A monoclonal antibody targeting amyloid \u03b2 (A \u03b2) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer \u2019 s disease. 13, 1.","DOI":"10.1371\/journal.pone.0195751"},{"key":"10.1016\/j.imbio.2023.152410_b0685","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation","volume":"8","author":"Le Quintrec","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.imbio.2023.152410_b0690","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.imbio.2023.152410_b0695","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2023.152410_b0700","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1002\/eji.1830251238","article-title":"Expression of the complement alternative pathway by human myoblasts in vitro: Biosynthesis of C3, factor B, factor H and factor I","volume":"25","author":"Legoedec","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0705","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0162-3109(97)00080-5","article-title":"Complement factor I deficiency in a family with recurrent infections","volume":"38","author":"Leitao","year":"1997","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.imbio.2023.152410_b0710","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00467-010-1734-4","article-title":"Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation","volume":"26","author":"Leroy","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_b0715","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1681\/ASN.2019040433","article-title":"Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy","volume":"31","author":"Levine","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.imbio.2023.152410_b0720","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ki.1986.278","article-title":"H deficiency in two brothers with atypical dense intramembranous deposit disease","volume":"30","author":"Levy","year":"1986","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2023.152410_b0725","doi-asserted-by":"crossref","first-page":"e9250","DOI":"10.7717\/peerj.9250","article-title":"Profiling tear proteomes of patients with unilateral relapsed Behcet's disease-associated uveitis using data-independent acquisition proteomics","volume":"8","author":"Liang","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.imbio.2023.152410_b0730","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.ki.5000269","article-title":"Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)","volume":"70","author":"Licht","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2023.152410_b0735","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.iy.09.040191.002243","article-title":"Membrane Cofactor Protein (MCP or CD46): Newest Member of the Regulators of Complement Activation Gene Cluster","volume":"9","author":"Liszewski","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0740","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s13277-014-2801-4","article-title":"Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population","volume":"36","author":"Liu","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.imbio.2023.152410_b0745","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1172\/JCI25843","article-title":"Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers","volume":"116","author":"Luibl","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.imbio.2023.152410_b0750","doi-asserted-by":"crossref","first-page":"e000361","DOI":"10.1136\/bmjophth-2019-000361","article-title":"Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging","volume":"5","author":"Lynch","year":"2020","journal-title":"BMJ Open Ophthalmology"},{"key":"10.1016\/j.imbio.2023.152410_b0755","first-page":"762","article-title":"Factor I deficiency, a regulator protein of complement","volume":"19","author":"Maillet","year":"1990","journal-title":"Presse Med."},{"key":"10.1016\/j.imbio.2023.152410_b0760","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1681\/ASN.2012020166","article-title":"A hybrid CFHR3-1 gene causes familial C3 glomerulopathy","volume":"23","author":"Malik","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.imbio.2023.152410_b0765","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/iovs.61.11.39","article-title":"Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy","volume":"61","author":"Mandava","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.imbio.2023.152410_b0770","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1167\/iovs.12-11073","article-title":"Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration","volume":"54","author":"Marsiglia","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.imbio.2023.152410_b0775","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.156.6.1739","article-title":"Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes","volume":"156","author":"Medof","year":"1982","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2023.152410_b0780","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1073\/pnas.87.10.3982","article-title":"Discrimination between activators and nonactivators of the alternative pathway of complement: Regulation via a sialic acid\/polyanion binding site on factor H","volume":"87","author":"Meri","year":"1990","journal-title":"PNAS"},{"key":"10.1016\/j.imbio.2023.152410_b0785","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0161-5890(95)00116-6","article-title":"cDNA cloning, sequencing and chromosomal assignment of the gene for mouse complement factor I (C3b\/C4b inactivator): identification of a species specific divergent segment in factor I","volume":"33","author":"Minta","year":"1996","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0790","first-page":"286","article-title":"Transcriptional and post-transcriptional regulation of complement factor I (CFI) gene expression in Hep G2 cells by interleukin-6","volume":"1442","author":"Minta","year":"1998","journal-title":"BBA"},{"key":"10.1016\/j.imbio.2023.152410_b0795","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2023.152410_b0800","first-page":"131","article-title":"Three cases of factor I deficiency: the effect of treatment with plasma","volume":"74","author":"Moller Rasmussen","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0805","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.arcped.2006.04.023","article-title":"Complement factor I deficiency revealed by repeated systemic Streptococcus pneumoniae infection","volume":"13","author":"Monfort-Gouraud","year":"2006","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.imbio.2023.152410_b0810","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2023.152410_b0815","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.imbio.2015.04.006","article-title":"The membrane attack complex as an inflammatory trigger","volume":"221","author":"Morgan","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2023.152410_b0820","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4049\/jimmunol.138.1.246","article-title":"Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis","volume":"138","author":"Morgan","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0825","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-160889","article-title":"The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease","volume":"56","author":"Morgan","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.imbio.2023.152410_b0830","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1172\/JCI110687","article-title":"Complement biosynthesis by the human hepatoma-derived cell line HepG2","volume":"70","author":"Morris","year":"1982","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.imbio.2023.152410_b0835","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/d41586-022-04327-7","article-title":"Researchers welcome $3.5-million haemophilia gene therapy - but questions remain","volume":"612","author":"Naddaf","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2023.152410_b0840","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaci.2020.08.014","article-title":"Plasma C3d levels as a diagnostic marker for complete complement factor I deficiency","volume":"147","author":"Naesens","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0845","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0019-2791(77)90345-7","article-title":"Mechanism of action of the C3b inactivator: Requiremen for a high molecular weight cofactor (C3b\u2013C4bINA cofactor) and production of a new C3b derivative (C3b\u2032)","volume":"14","author":"Nagasawa","year":"1977","journal-title":"Immunochemistry"},{"key":"10.1016\/j.imbio.2023.152410_b0850","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clim.2000.4878","article-title":"Deficiency of human complement factor I associated with lowered factor H","volume":"96","author":"Naked","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0855","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3389\/fimmu.2018.00735","article-title":"Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I","volume":"9","author":"Nanthapisal","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0860","first-page":"259","article-title":"The alternate pathway of complement activation","volume":"24","author":"Nicol","year":"1973","journal-title":"Immunology"},{"key":"10.1016\/j.imbio.2023.152410_b0865","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.molimm.2006.10.005","article-title":"A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation","volume":"44","author":"Nilsson","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0870","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.imbio.2012.07.008","article-title":"The tick-over theory revisited: Is C3 a contact-activated protein?","volume":"217","author":"Nilsson","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2023.152410_b0875","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/eji.200838702","article-title":"Genetic, molecular and functional analyses of complement factor I deficiency","volume":"39","author":"Nilsson","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0880","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/eji.200939280","article-title":"Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I","volume":"40","author":"Nilsson","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0885","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1074\/jbc.M109.097212","article-title":"Analysis of binding sites on complement factor I that are required for its activity","volume":"285","author":"Nilsson","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2023.152410_b0890","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.molimm.2011.04.004","article-title":"Complement factor I in health and disease","volume":"48","author":"Nilsson","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0895","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.molimm.2011.01.012","article-title":"Molecular characterization of two novel cases of complete complement inhibitor Factor I deficiency","volume":"48","author":"Nita","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0900","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-94-017-8881-6_3","article-title":"Evolution of the complement system","volume":"80","author":"Nonaka","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.imbio.2023.152410_b0905","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_b0910","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molimm.2007.04.025","article-title":"Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors","volume":"45","author":"Okroj","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0915","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.celrep.2019.12.082","article-title":"Integration of eQTL and a single-cell atlas in the human eye identifies causal genes for age-related macular degeneration","volume":"30","author":"Orozco","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.imbio.2023.152410_b0920","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.1701695","article-title":"Statistical validation of rare complement variants provides insights into the molecular basis of atypical hemolytic uremic syndrome and C3 glomerulopathy","volume":"200","author":"Osborne","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0925","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1073\/pnas.75.5.2416","article-title":"Complement C3 convertase: Cell surface restriction of \u03b21H control and generation of restriction on neuraminidase-treated cells","volume":"75","author":"Pangburn","year":"1978","journal-title":"PNAS"},{"key":"10.1016\/j.imbio.2023.152410_b0930","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.1983.tb18116.x","article-title":"Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3","volume":"421","author":"Pangburn","year":"1983","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.imbio.2023.152410_b0935","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1084\/jem.146.1.257","article-title":"Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution","volume":"146","author":"Pangburn","year":"1977","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2023.152410_b0940","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.imbio.2011.10.003","article-title":"Complement Factor H-ligand interactions: Self-association, multivalency and dissociation constants","volume":"217","author":"Perkins","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2023.152410_b0945","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled c3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor h","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0950","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/j.molimm.2008.02.008","article-title":"Molecular characterization of Complement Factor I deficiency in two Spanish families","volume":"45","author":"Ponce-Castro","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0955","first-page":"463","article-title":"Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients","volume":"66","author":"Porteu","year":"1986","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0960","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/jmedgenet-2015-103130","article-title":"Rare genetic variants in Tunisian Jewish patients suffering from age-related macular degeneration","volume":"52","author":"Pras","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0965","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13073-015-0183-x","article-title":"Restoration of mesenchymal retinal pigmented epithelial cells by TGF\u03b2 pathway inhibitors: implications for age-related macular degeneration","volume":"7","author":"Radeke","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.imbio.2023.152410_b0970","first-page":"3888734","article-title":"Sequential increase in complement factor I, iC3b, and Cells Expressing CD11b or CD14 in Cutaneous Vasculitis","volume":"2022","author":"Rahkola","year":"2022","journal-title":"Anal. Cell. Pathol. (Amst.)"},{"key":"10.1016\/j.imbio.2023.152410_b0975","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/exd.14349","article-title":"Complement factor I upregulates expression of matrix metalloproteinase-13 and -2 and promotes invasion of cutaneous squamous carcinoma cells","volume":"30","author":"Rahmati Nezhad","year":"2021","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.imbio.2023.152410_b0980","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-3083.1986.tb02008.x","article-title":"A family with complement factor I deficiency","volume":"23","author":"Rasmussen","year":"1986","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b0985","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41588-019-0351-9","article-title":"Retinal transcriptome and eQTL analyses identify genes associated with age-related macular degeneration","volume":"51","author":"Ratnapriya","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b0990","article-title":"Clinicopathologic implications of complement genetic variants in kidney transplantation","volume":"8","author":"Ren","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.imbio.2023.152410_b0995","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.imbio.2023.152410_b1000","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-2776(07)96004-6","article-title":"Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration","volume":"96","author":"Richards","year":"2007","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12500","article-title":"Complement component C3 \u2013 The \u201cSwiss Army Knife\u201d of innate immunity and host defense","volume":"274","author":"Ricklin","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2023.152410_b1010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/jid.2014.376","article-title":"Complement factor I promotes progression of cutaneous squamous cell carcinoma","volume":"135","author":"Riihila","year":"2015","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.imbio.2023.152410_b1015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj2490593","article-title":"The complete amino acid sequence of human complement factor H","volume":"249","author":"Ripoche","year":"1988","journal-title":"Biochem. J"},{"key":"10.1016\/j.imbio.2023.152410_b1020","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1084\/jem.168.5.1917","article-title":"Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture","volume":"168","author":"Ripoche","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2023.152410_b1025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1352458508100047","article-title":"Protein expression profiles in pediatric multiple sclerosis: potential biomarkers","volume":"15","author":"Rithidech","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.imbio.2023.152410_b1030","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.161.5.1189","article-title":"Human genes for three complement components that regulate the activation of C3 are tightly linked","volume":"161","author":"Rodriguez de Cordoba","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2023.152410_b1035","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a006239","article-title":"Rapid genome sequencing identifies novel variants in complement factor I","volume":"8","author":"Rodriguez","year":"2022","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"10.1016\/j.imbio.2023.152410_b1040","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.kint.2020.01.035","article-title":"The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment","volume":"97","author":"Rondeau","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2023.152410_b1045","first-page":"608","article-title":"Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice","volume":"118","author":"Rose","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.imbio.2023.152410_b1050","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.oret.2018.03.001","article-title":"A randomized phase 2 study of an anti-amyloid \u03b2 monoclonal antibody in geographic atrophy secondary to age-related macular degeneration","volume":"2","author":"Rosenfeld","year":"2018","journal-title":"Ophthalmology. Retina"},{"key":"10.1016\/j.imbio.2023.152410_b1055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1084\/jem.158.2.334","article-title":"Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin","volume":"158","author":"Ross","year":"1983","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2023.152410_b1060","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1102167108","article-title":"Structural basis for complement factor I control and its disease-associated sequence polymorphisms","volume":"108","author":"Roversi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imbio.2023.152410_b1065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaophthalmol.2015.5592","article-title":"Rare genetic variants associated with development of age-related macular degeneration","volume":"134","author":"Saksens","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.imbio.2023.152410_b1070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.909503","article-title":"Post-transplant thrombotic microangiopathy due to a pathogenic mutation in complement factor I in a patient with membranous nephropathy: case report and review of literature","volume":"13","author":"Saleem","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1075","doi-asserted-by":"crossref","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.imbio.2023.152410_b1080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/humu.20435","article-title":"The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models","volume":"28","author":"Saunders","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.imbio.2023.152410_b1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox9090793","article-title":"Properdin modulates complement component production in stressed human primary retinal pigment epithelium cells","volume":"9","author":"Sch\u00e4fer","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.imbio.2023.152410_b1090","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/eye.2016.328","article-title":"Local complement activation in aqueous humor in patients with age-related macular degeneration","volume":"31","author":"Schick","year":"2017","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.imbio.2023.152410_b1095","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-2567.1999.00886.x","article-title":"Rat complement factor I: molecular cloning, sequencing and expression in tissues and isolated cells","volume":"98","author":"Schlaf","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.imbio.2023.152410_b1100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0161-5890(01)00045-1","article-title":"Expression and regulation of complement factors H and I in rat and human cells: Some critical notes","volume":"38","author":"Schlaf","year":"2001","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1105","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.181.4.2610","article-title":"A new map of glycosaminoglycan and C3b binding sites on factor H","volume":"181","author":"Schmidt","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1110","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/ng.2741","article-title":"Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration","volume":"45","author":"Seddon","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b1115","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.imbio.2023.152410_b1120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2006.045328","article-title":"Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome","volume":"44","author":"Servais","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b1125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2023.152410_b1130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12879-016-2107-9","article-title":"Increased activity of the complement system in cerebrospinal fluid of the patients with Non-HIV Cryptococcal meningitis","volume":"17","author":"Shen","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.imbio.2023.152410_b1135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0888-7543(89)90318-2","article-title":"Mapping of the human complement factor I gene to 4q25","volume":"4","author":"Shiang","year":"1989","journal-title":"Genomics"},{"key":"10.1016\/j.imbio.2023.152410_b1140","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3389\/fimmu.2019.01150","article-title":"Classical and non-classical presentations of complement factor I deficiency: two contrasting cases diagnosed via genetic and genomic methods","volume":"10","author":"Shields","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1145","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.molimm.2009.04.002","article-title":"Characterization of shark complement factor I gene(s): Genomic analysis of a novel shark-specific sequence","volume":"46","author":"Shin","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1150","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0019-2791(75)90256-6","article-title":"Cleavage products of C4b produced by enzymes in human serum","volume":"12","author":"Shiraishi","year":"1975","journal-title":"Immunochemistry"},{"key":"10.1016\/j.imbio.2023.152410_b1155","doi-asserted-by":"crossref","DOI":"10.3390\/genes10100825","article-title":"Rare genetic variants in jewish patients suffering from age-related macular degeneration","volume":"10","author":"Shoshany","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.imbio.2023.152410_b1160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/bj1980509","article-title":"Binding of fluid-phase complement components C3 and C3b to human lymphocytes","volume":"198","author":"Sim","year":"1981","journal-title":"Biochem. J."},{"key":"10.1016\/j.imbio.2023.152410_b1165","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00417-020-04910-6","article-title":"Association of imaging biomarkers and local activation of complement in aqueous humor of patients with early forms of age-related macular degeneration","volume":"259","author":"Sitnilska","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.imbio.2023.152410_b1170","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.molimm.2008.09.018","article-title":"Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation","volume":"46","author":"Sj\u00f6berg","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy - understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_b1180","first-page":"197","article-title":"C3b inactivator deficiency with immune complex manifestations","volume":"47","author":"Solal-Celigny","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1185","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.649801","article-title":"Generation and characterization of mouse models of C3 glomerulonephritis with CFI D288G and P467S mutations","volume":"12","author":"Song","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.imbio.2023.152410_b1190","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.xphs.2021.03.024","article-title":"Manufacturing challenges and rational formulation development for AAV Viral vectors","volume":"110","author":"Srivastava","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.imbio.2023.152410_b1195","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41598-020-58510-9","article-title":"A transcriptome-wide association study based on 27 tissues identifies 106 genes potentially relevant for disease pathology in age-related macular degeneration","volume":"10","author":"Strunz","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imbio.2023.152410_b1200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2016.01.003","article-title":"Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome","volume":"71","author":"Szarvas","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1205","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1167\/iovs.16-20867","article-title":"Systematic functional testing of rare variants: contributions of CFI to age-related macular degeneration","volume":"58","author":"Tan","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.imbio.2023.152410_b1210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-3083.1984.tb01005.x","article-title":"Factor I deficiency and C3 nephritic factor: immunochemical findings and association with Neisseria meningitidis infection in two patients","volume":"20","author":"Teisner","year":"1984","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0145-305X(01)00089-1","article-title":"Conservation of the modular structure of complement factor I through vertebrate evolution","volume":"26","author":"Terado","year":"2002","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1220","doi-asserted-by":"crossref","first-page":"e28527","DOI":"10.1371\/journal.pone.0028527","article-title":"Plasma biomarkers of brain atrophy in Alzheimer's disease","volume":"6","author":"Thambisetty","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.imbio.2023.152410_b1225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ijlh.13954","article-title":"Diagnosis and treatment of thrombotic microangiopathy","volume":"44","author":"Thompson","year":"2022","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.imbio.2023.152410_b1230","first-page":"23","article-title":"A second case of human C3b inhibitor (KAF) deficiency","volume":"27","author":"Thompson","year":"1977","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1235","doi-asserted-by":"crossref","unstructured":"Thurman, J.M., Laskowski, J., Nemenoff, R.A. 2020. Complement and Cancer-A Dysfunctional Relationship? Antibodies (Basel) 9.","DOI":"10.3390\/antib9040061"},{"key":"10.1016\/j.imbio.2023.152410_b1240","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molimm.2005.02.009","article-title":"Human keratinocytes produce the complement inhibitor factor H: Synthesis is regulated by interferon-\u03b3","volume":"43","author":"Tim\u00e1r","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1245","article-title":"Concomitant factor I and IgA deficiencies","volume":"68","author":"Tottori","year":"1992","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1250","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.18632\/oncotarget.23907","article-title":"Serum complement factor I is associated with disease activity of systemic lupus erythematosus","volume":"9","author":"Tseng","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.imbio.2023.152410_b1255","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4049\/jimmunol.173.1.367","article-title":"Human complement factor I does not require cofactors for cleavage of synthetic substrates","volume":"173","author":"Tsiftsoglou","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1260","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1021\/bi047680t","article-title":"The catalytically active serine protease domain of human complement factor I","volume":"44","author":"Tsiftsoglou","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.imbio.2023.152410_b1265","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.bbapap.2006.09.007","article-title":"Human complement factor I glycosylation: Structural and functional characterisation of the N-linked oligosaccharides","volume":"1764","author":"Tsiftsoglou","year":"2006","journal-title":"Biochim. Biophys. Acta Protein Proteomics"},{"key":"10.1016\/j.imbio.2023.152410_b1270","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/hmg\/ddac060","article-title":"Rare complement factor I variants associated with reduced macular thickness and age-related macular degeneration in the UK Biobank","volume":"31","author":"Tzoumas","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b1275","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/cei.13490","article-title":"Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency(1)","volume":"202","author":"Ugrinovic","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1280","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/ng.2640","article-title":"A functional variant in the CFI gene confers a high risk of age-related macular degeneration","volume":"45","author":"van de Ven","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2023.152410_b1285","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/j.1462-5822.2007.00981.x","article-title":"Macrophage complement receptors and pathogen clearance","volume":"9","author":"van Lookeren Campagne","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.imbio.2023.152410_b1290","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer","volume":"28","author":"Verdera","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.imbio.2023.152410_b1295","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/geno.1994.1585","article-title":"The organization of the human complement factor I gene (IF) A member of the serine protease gene family","volume":"24","author":"Vyse","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.imbio.2023.152410_b1300","first-page":"385","article-title":"Hereditary complement factor I deficiency","volume":"87","author":"Vyse","year":"1994","journal-title":"QJM: Internat. J. Med."},{"key":"10.1016\/j.imbio.2023.152410_b1305","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1172\/JCI118515","article-title":"The molecular basis of hereditary complement factor I deficiency","volume":"97","author":"Vyse","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2023.152410_b1310","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF00915141","article-title":"C3b inactivator deficiency: association with an alpha-migrating factor H","volume":"1","author":"Wahn","year":"1981","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1315","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2023.152410_b1320","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2023.152410_b1325","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4049\/jimmunol.181.1.712","article-title":"Altered function of factor I caused by amyloid \u03b2: implication for pathogenesis of age-related macular degeneration from drusen","volume":"181","author":"Wang","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1330","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2023.152410_b1335","first-page":"3268","article-title":"Control of the amplification convertase of complement by the plasma protein j1lH (amplification convertase inhibitor\/C3b inactivator\/properdin\/C3 nephritic factor\/alternative complement pathway)","volume":"73","author":"Weiler","year":"1976","journal-title":"Immunology"},{"key":"10.1016\/j.imbio.2023.152410_b1340","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12882-018-0952-z","article-title":"C3 glomerulonephritis and thrombotic microangiopathy of renal allograft after pulmonary infection in a male with concomitant two complement factor I gene variations: a case report","volume":"19","author":"Wen","year":"2018","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_b1345","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1084\/jem.151.3.501","article-title":"Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes","volume":"151","author":"Whaley","year":"1980","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2023.152410_b1350","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1084\/jem.144.5.1147","article-title":"Modulation of the alternative complement pathway by \u03b21H globulin*","volume":"144","author":"Whaley","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2023.152410_b1355","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1126\/science.948757","article-title":"Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator","volume":"193","author":"Whaley","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.imbio.2023.152410_b1360","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/310476a0","article-title":"Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse","volume":"310","author":"Williams","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2023.152410_b1365","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1681\/ASN.2013070732","article-title":"Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN","volume":"25","author":"Wong","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.imbio.2023.152410_b1370","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0161-5890(94)00151-P","article-title":"Processing of human factor I in COS-1 cells co-transfected with factor I and paired basic amino acid cleaving enzyme (PACE) cDNA","volume":"32","author":"Wong","year":"1995","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00281-017-0663-8","article-title":"Diseases of complement dysregulation-an overview","volume":"40","author":"Wong","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.imbio.2023.152410_b1380","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2215\/CJN.00320121","article-title":"C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes","volume":"16","author":"Wong","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2023.152410_b1385","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.imbio.2023.152410_b1390","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.dci.2015.06.010","article-title":"Complement factor I from flatfish half-smooth tongue (Cynoglossus semilaevis) exhibited anti-microbial activities","volume":"53","author":"Xiang","year":"2015","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1395","first-page":"643","article-title":"Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses","volume":"24","author":"Xue","year":"2017","journal-title":"Nat. Publ. Group"},{"key":"10.1016\/j.imbio.2023.152410_b1400","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imbio.2023.152410_b1405","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"Yates","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2023.152410_b1410","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1177\/1352458519887905","article-title":"Cerebrospinal fluid complement system biomarkers in demyelinating disease","volume":"26","author":"Zelek","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.imbio.2023.152410_b1415","article-title":"Complement Factor I Variants in Complement-Mediated Renal Diseases","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152410_b1420","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1172\/JCI107975","article-title":"Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency","volume":"55","author":"Ziegler","year":"1975","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2023.152410_b1425","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2019040331","article-title":"Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome","volume":"30","author":"Zuber","year":"2019","journal-title":"J Am Soc Nephrol"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:51:19Z","timestamp":1759251079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298523000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":286,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0171298523000785"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152410","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152410"}}